P38 Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.052
https://www.valueinhealthjournal.com/article/S1098-3015(25)00176-7/fulltext
Title :
P38 Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)00176-7&doi=10.1016/j.jval.2025.04.052
First page :
Section Title :
Open access? :
No
Section Order :
10247